RT @doctorRBC: JUNIPERA - secukinumab in enthesitis related arthritis and juvenile PsA âï¸achieved JIA ACR response c
Tweet Content
JUNIPERA - secukinumab in enthesitis related arthritis and juvenile PsA
⭐️achieved JIA ACR response compared to placebo
⭐️⬇️time to flare
⭐️75% with resolution of enthesitis
⭐️0 deaths, AE - minor infections, GI issues, headache
Abs#LB0004
#EULAR2021 @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off